These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3229005)

  • 1. Inhibition of alpha-tocopherol and calcium calmodulin-stimulated phosphodiesterase activity in vitro by anthracyclines.
    Nwankwoala RN; West WL
    Clin Exp Pharmacol Physiol; 1988 Nov; 15(11):805-14. PubMed ID: 3229005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetiedil inhibition of calmodulin-stimulated enzyme activity.
    Levine SN; Berkowitz LR; Orringer EP
    Biochem Pharmacol; 1984 Feb; 33(4):581-4. PubMed ID: 6231031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin and alpha tocopherol as additional binding sites for doxorubicin.
    Nwankwoala RN; West WL
    Cancer Chemother Pharmacol; 1986; 16(2):133-8. PubMed ID: 3004771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.
    Law J; Fumagalli A; Schein PS; Rahman A
    Life Sci; 1985 Feb; 36(6):589-99. PubMed ID: 2982070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
    Muszyńska A; Wolczyński S; Pałka J
    Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
    Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
    Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprindine inhibits calmodulin-stimulated phosphodiesterase and Ca-ATPase activities.
    Levine SN; Hollier B
    J Cardiovasc Pharmacol; 1983; 5(1):151-6. PubMed ID: 6186851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
    Kakkar R; Raju RV; Rajput AH; Sharma RK
    Brain Res; 1997 Feb; 749(2):290-4. PubMed ID: 9138729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.
    Burke BE; Mushlin PS; Cusack BJ; Olson SJ; Gambliel HA; Olson RD
    Cardiovasc Toxicol; 2002; 2(1):41-51. PubMed ID: 12189279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
    Swift L; McHowat J; Sarvazyan N
    Cancer Res; 2003 Sep; 63(18):5992-8. PubMed ID: 14522926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin inhibitors and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate do not prevent the inhibitory effect of prostaglandin F2 alpha on cyclic AMP production in isolated rat corpora lutea.
    Lahav M; Rennert H; Sabag K; Barzilai D
    J Endocrinol; 1987 May; 113(2):205-12. PubMed ID: 3035050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart.
    Temma K; Akera T; Chugun A; Kondo H; Hagane K; Hirano S
    Eur J Pharmacol; 1993 Apr; 234(2-3):173-81. PubMed ID: 8482324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of calmodulin stimulation of phosphodiesterase and Ca2+, Mg2+-ATPase activities and shape change of erythrocyte ghosts by chloroquine.
    Nagai F; Ushiyama K; Kano I; Nakagawa A; Nakao T; Nakajima A
    Biochem Pharmacol; 1987 Oct; 36(20):3433-7. PubMed ID: 2960325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Hintzpeter J; Seliger JM; Hofman J; Martin HJ; Wsol V; Maser E
    Toxicol Appl Pharmacol; 2016 Feb; 293():21-9. PubMed ID: 26773812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on collagenase inhibitors. III. Inhibitory effects of anthracyclines on bacterial collagenase].
    Tanaka T; Metori K; Mineo S; Matsumoto H; Satoh T
    Yakugaku Zasshi; 1991 Jan; 111(1):70-2. PubMed ID: 1647453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allosteric regulation of Ca2+-calmodulin-dependent phosphodiesterase activity from the bovine brain].
    Bobruskin ID; Shaĭkhin SM; Muratova MV; Baranova LA; Severin ES
    Biokhimiia; 1987 Aug; 52(8):1344-52. PubMed ID: 2822149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B is a selective and potent antagonist of calmodulin.
    Hegemann L; van Rooijen LA; Traber J; Schmidt BH
    Eur J Pharmacol; 1991 May; 207(1):17-22. PubMed ID: 1915592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.